Limited availability of subcutaneous immunoglobulins
December 22, 2021
Due to a decrease in the availability of subcutaneous immunoglobulins around the world, there is also a critical level of limited availability in Belgium. The FAMHP issues several recommendations for hospital and retail pharmacists, medical doctors (specialists), and patients.
Fewer subcutaneous immunoglobulins (SCIgs) have been available since July 2021, and the reasons for this are the reduced collection of plasma around the world, the ever increasing need for immunoglobulins, and the dependence on plasma from other countries. The shortage is persistently noticeable but has been exacerbated by the COVID-19 situation.